Rx SEDATIVE CONTRACEPTIVE AND DIURETIC PRICES
Rx SEDATIVE CONTRACEPTIVE AND DIURETIC PRICES remained flat during the four-month period ended June 30, according to just-released Producer Price lndex data from the Labor Dept.'s Bureau of Labor Statistics. The bureau's figures, released July 12, indicate that from February through June contraceptive and sedative prices remained unchanged. Prices for diuretics edged up 0.2%. The contraceptive category has shown no increase through the first six months of 1985, while diuretics are up 4.2%. The sedative group, however, has increased 17.4% since the beginning of the year. Overall ethical drug prices are increasing at about a 9% annual pace. Through six months the index is up 4.5%. The pharmaceutical figures are still running well ahead of the index for finished goods, which is up only 0.5% through June. Ethicals with the largest growth for the four month period include bronchial therapy products, which jumped 10.3%, and central nervous system stimulants, which increased 8.9%.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth